RBCs break into fragments, they are referred to as schistocytes. These type of cells are seen in
Rationale:
Schistocytes are seen in microangiopathic haemolytic anaemia, where small blood vessel damage leads to red blood cell fragmentation. This condition often results from disorders like thrombotic thrombocytopenic purpura or hemolytic uremic syndrome, which cause mechanical destruction of RBCs.
A: Thalassaemia involves abnormal hemoglobin production, leading to ineffective erythropoiesis rather than fragmentation of red blood cells.
C: Idiopathic thrombocytopenic purpura primarily affects platelets, causing low platelet counts without direct RBC fragmentation.
D: Gilbert's syndrome is a benign condition affecting bilirubin metabolism, with no direct impact on red blood cell structure or fragmentation.
Which of the following medications is used to prevent or treat thrombosis in clients who cannot take heparin due to heparin induced thrombocytopenia.
Rationale:
Argatroban is utilized to prevent or treat thrombosis in clients who cannot receive heparin, particularly in cases of heparin-induced thrombocytopenia, due to its direct thrombin-inhibiting properties.
B: Fondaparinux targets factor Xa and is not indicated for patients with heparin-induced thrombocytopenia, limiting its application in this specific patient population requiring alternative anticoagulation strategies.
C: Dabigatran acts as a direct thrombin inhibitor but is not recommended for use in patients with a history of heparin-induced thrombocytopenia, making it unsuitable for this context.
D: Desirudin, a direct thrombin inhibitor, lacks approval for use in patients with heparin-induced thrombocytopenia, thus failing to meet the needs of clients seeking alternatives to heparin therapy.
A patient had a deep vein thrombosis (DVT) and was on heparin and warfarin in the hospital and discharged home on warfarin. She asks her primary care nurse practitioner (NP) why she was getting both medications while in the hospital. The best response is to:
Rationale:
Warfarin is often started while a patient is still on heparin because warfarin takes a few days to reach effectiveness. This dual therapy ensures immediate anticoagulation while allowing for the gradual buildup of warfarin's therapeutic effects.
A: Contact the hospitalist as this is not the normal guideline for prescribing these two medications and she may have had a more complicated case. This scenario aligns with standard practice, indicating no unusual complications.
C: Encourage the patient to contact the customer service department at the hospital, as this was most likely a medication error during her admission. No evidence suggests a medication error occurred, as the treatment was appropriate for DVT management.
D: Draw anticoagulation studies to make sure she does not have dangerously high bleeding times. This action is unnecessary given the patient's stable condition and existing anticoagulation management with warfarin.
Aspirin 325 mg should be taken during initial acute episode of myocardial infarction. Which of the following medications can often be prescribed concurrently with aspirin and increase the risk for bleeding?
Rationale:
Clopidogrel can often be prescribed concurrently with aspirin and increase the risk for bleeding due to its antiplatelet effects, which can enhance the bleeding risk during acute myocardial infarction management.
B: Warfarin, while it does increase bleeding risk, is not typically prescribed concurrently with aspirin in acute myocardial infarction, as its effects are more prolonged and distinct from clopidogrel.
C: Thrombin, although it may be associated with bleeding risks, is not commonly used alongside aspirin in acute myocardial infarction scenarios, making it less relevant in this context.
D: All of the above includes options that are not typically prescribed concurrently with aspirin in acute myocardial infarction, thus diluting the specificity of the risk associated with clopidogrel.
A patient on oral anticoagulant therapy is commenced on sulfamethoxazole-trimethoprim, double-strength twice daily. One may expect to see the INR
Rationale:
Oral anticoagulant therapy can be influenced by sulfamethoxazole-trimethoprim, which may lead to an increased INR due to its potential to inhibit metabolic pathways involved in anticoagulant clearance.
B: If III only is correct (Remain unchanged) The interaction of sulfamethoxazole-trimethoprim with anticoagulants typically results in an increased INR, suggesting that levels would not remain unchanged under these circumstances.
C: If I and II are correct (Increase and Decrease) While an increase in INR is expected, the notion of a decrease contradicts established pharmacological interactions, making this option inconsistent with the expected outcome.
D: If II and III are correct (Decrease and Remain unchanged) Anticipating both a decrease and unchanged INR contrasts with the known impact of sulfamethoxazole-trimethoprim, which primarily raises anticoagulant levels rather than lowering them.
A nurse is treating a 75-year-old female patient who'd receiving heparin therapy for recurring deep vein thromboses. Before discharging the patient, the nurse should advise her to monitor for which of the following symptoms?
Rationale:
D: All of the above. Monitoring for increased heart rate, decreased blood pressure, bruising, petechiae, hematomas, and black tarry stools is crucial for patients on heparin therapy, as these symptoms indicate potential bleeding complications or adverse reactions to treatment.
A: Increased heart rate and decreased blood pressure. These symptoms indicate possible cardiovascular instability or significant blood loss, which are critical signs to monitor but not specific to heparin therapy alone.
B: Bruising and petechiae. While these symptoms are relevant to bleeding risks associated with heparin, they do not encompass the full spectrum of potentially dangerous signs a patient should observe.
C: Hematomas and black tarry stools. Both signs indicate serious bleeding conditions, yet they represent only part of the monitoring needed for a patient on heparin therapy, lacking comprehensive coverage.
A nurse caring for a patient diagnosed with Cystic Fibrosis should understand that the expected pharmacological action of Acetylcysteine is to
Rationale:
Acetylcysteine thins and enhances the flow of secretions in the respiratory passages. This action is vital for patients with Cystic Fibrosis, as it helps clear mucus and improve lung function.
B: dilate the upper respiratory passageways. This option describes a mechanism that is not characteristic of Acetylcysteine, which focuses on mucus management rather than airway dilation.
C: agonize respiratory b2 adrenergic receptors. This option mistakenly attributes an action that is associated with bronchodilators, which is not relevant to the mucolytic properties of Acetylcysteine.
D: antagonize a1 cholinergic receptors. This option incorrectly implies a role in blocking cholinergic receptors, which does not align with Acetylcysteine's primary function of mucolysis.
To avoid a theophylline toxicity in her patients, a nurse should decrease the dosage of this medication when administering it concurrently with which of the following medications?
Rationale:
To avoid a theophylline toxicity in her patients, a nurse should decrease the dosage of this medication when administering it concurrently with cimetidine, ciprofloxacin, and other fluoroquinolone antibiotics.
Cimetidine, ciprofloxacin, and fluoroquinolones inhibit the metabolism of theophylline, leading to increased drug levels in the body. This interaction heightens the risk of toxicity, necessitating dosage adjustments to ensure patient safety and effective treatment.
B: Phenobarbital, phenytoin, and rifampin enhance theophylline metabolism, reducing its efficacy. The nurse would not need to lower the dosage when these medications are co-administered.
C: Albuterol and TCAs do not significantly alter theophylline metabolism. Concurrent use typically does not necessitate dosage adjustments, as they do not pose a risk of toxicity.
D: The assertion that none of the listed drugs pose a risk is misleading. Certain medications, particularly those listed in option A, do indeed require caution when used with theophylline.
A patient is traveling to Southeast Asia on vacation and has come into the clinic to review their medications. They are healthy with only mild hypertension that is well controlled. They ask about getting 'a shot' to prevent blood clots like their friend did before international travel. The correct response would be to:
Rationale:
Travelers with mild hypertension and no significant risk factors for blood clots do not require prophylactic treatment. Education on prevention strategies, such as hydration and movement, is appropriate for this patient.
A: Administer one dose of low-molecular-weight heparin 24 hours before travel. This approach is reserved for individuals with higher risk factors for venous thromboembolism, which this patient does not exhibit.
B: Prescribe one dose of warfarin to be taken the day of travel. Warfarin requires careful monitoring and is not suitable as a one-time preventive measure for someone with low risk.
C: Consult with a hematologist regarding a treatment plan for the patient. This is unnecessary when the patient has no significant risk factors and can be managed with basic preventative education.
A patient taking carbamazepine needs to be started on a direct factor Xa inhibitor for antithrombotic therapy. Which of the direct factor Xa inhibitors should be avoided due to drug interactions?
Rationale:
C: Rivaroxaban should be avoided due to significant interactions with carbamazepine, which induces CYP enzymes, leading to increased metabolism and reduced effectiveness of rivaroxaban, compromising anticoagulation therapy.
A: Betrixaban has minimal interactions with carbamazepine, making it a safer choice for patients in need of antithrombotic therapy, thus ensuring therapeutic efficacy without the risk of significant drug interactions.
B: Apixaban is less affected by carbamazepine's enzyme-inducing effects compared to rivaroxaban, making it a viable option for antithrombotic therapy without the same level of concern regarding efficacy.
D: Edoxaban presents a lower interaction risk with carbamazepine, allowing for effective antithrombotic therapy while maintaining stable drug levels, unlike the significant interaction expected with rivaroxaban.
A 72 year old male with enlargement of superficial lymph nodes and mild hepatosplenomegaly is diagnosed as having chronic lymphatic leukaemia (CLL). The most important criteria for diagnosis of this disease is the
Rationale:
Absolute lymphocytosis is the most important criterion for diagnosing chronic lymphatic leukaemia (CLL). This condition is characterized by a significant increase in lymphocyte count, which is pivotal for confirming the disease diagnosis.
A: Presence of hypogammaglobulinaemia indicates a potential immune deficiency but is not a definitive diagnostic criterion for CLL, thus making it a less critical indicator.
C: Male predominance highlights a statistical trend in CLL cases but does not contribute directly to the diagnosis or the identification of the disease in an individual patient.
D: Presence of enlarged lymph nodes can suggest lymphatic involvement, yet it is not exclusive to CLL and does not serve as the primary diagnostic marker.
The anticoagulant effects of heparin can be promptly arrested by administration of
Rationale:
Protamine sulfate. This agent directly neutralizes the anticoagulant effects of heparin, effectively reversing its action in a clinical setting and restoring normal blood coagulation rapidly.
A: Epsilon amino caproic acid This compound primarily inhibits fibrinolysis, which does not counteract the anticoagulant properties of heparin and thus fails to restore coagulation levels.
C: Adrenaline This hormone primarily functions to increase heart rate and blood pressure, having no role in reversing heparin's anticoagulant effects or influencing clotting factors directly.
D: Vitamin K This vitamin is essential for synthesizing certain clotting factors but does not have a role in reversing heparin's effects, making it ineffective in this context.
Beta 2 adrenergic agonists act by selectively activating the beta 2 receptors in the bronchial smooth muscle, resulting in bronchodilation. As a result of this
Rationale:
Beta 2 adrenergic agonists act by selectively activating the beta 2 receptors in the bronchial smooth muscle, resulting in bronchodilation. As a result of this, bronchospasm is relieved.
The activation of beta 2 receptors leads to relaxation of bronchial smooth muscle, which effectively dilates the airways and alleviates bronchospasm. This mechanism is crucial for improving airflow and relieving symptoms in conditions like asthma and COPD.
B: histamine release is potentiated. Beta 2 agonists do not enhance histamine release; instead, they primarily focus on relaxing smooth muscle rather than promoting inflammatory mediators.
C: ciliary motility is decreased. The action of beta 2 agonists is not to diminish ciliary activity; they primarily aim to facilitate bronchodilation and improve airway function.
D: All of the above. Not all statements are accurate; only the relief of bronchospasm is a direct consequence of beta 2 agonist action, while the others do not apply.
A pediatric nurse is treating an 8-year-old boy who was admitted through the ER with symptoms of hallucinations, incoordination and seizures. Based on the patient's clinical presentation, the nurse correctly concludes acute toxicity with
Rationale:
Acute toxicity with antihistamines is indicated due to the child's symptoms of hallucinations, incoordination, and seizures. These effects are commonly associated with overdose or toxicity from antihistamines, which can lead to central nervous system disturbances.
B: Decongestants. While decongestants can cause some central nervous system effects, they typically do not present with hallucinations or seizures, making them less likely in this scenario.
C: Mucolytics. Mucolytics primarily assist with mucus clearance and do not cause neurological symptoms such as hallucinations or seizures, thus they do not fit the clinical presentation.
D: Acetaminophen. Acetaminophen toxicity usually results in hepatic damage and does not typically lead to neurological symptoms like hallucinations or seizures, making it an unlikely cause in this case.
Unfractionated heparin binds to antithrombin III and inactivates clotting factor(s).
Rationale:
Unfractionated heparin binds to antithrombin III and inactivates all relevant clotting factors, specifically factor Xa and factor IIa, thereby preventing thrombus formation effectively.
D: All of the above encompasses both factor Xa and factor IIa, representing the broad spectrum of heparin's anticoagulant action through its interaction with antithrombin III.
A: Xa specifically refers to factor Xa, but does not account for factor IIa, which is also inactivated by heparin.
B: 1 x 0 does not pertain to any clotting factors and lacks relevance in the context of heparin's mechanism of action.
C: IIa focuses solely on factor IIa, neglecting factor Xa, thus failing to capture the full range of heparin's anticoagulant effects.
Which of the following requires IL-2 and IL-4 in the conversion of unilineage progenitor cell into mature circulating cell?
Rationale:
D: B lymphocyte requires IL-2 and IL-4 for its maturation from unilineage progenitor cells. These interleukins play a crucial role in promoting differentiation and proliferation, essential for developing functional B cells capable of producing antibodies.
A: Neutrophil development does not rely on IL-2 and IL-4; it primarily involves other growth factors such as GM-CSF and G-CSF for maturation and activation.
B: Eosinophil maturation is driven by IL-5 and other cytokines, rather than IL-2 and IL-4, which specifically target B lymphocyte development and function in the immune response.
C: Basophil differentiation is influenced by IL-3 and other signals, not IL-2 and IL-4, making it distinct in its developmental requirements compared to B lymphocytes.
Myelodysplastic syndromes are a group of clonal stem cell disorders. Which of the following type has the poorest prognosis according to the FAB system of classifications?
Rationale:
RA with excess blasts in transformation has the poorest prognosis according to the FAB system of classifications. This classification indicates a significant increase in blast cells, suggesting a severe progression of the disease and a higher likelihood of transformation to acute myeloid leukemia, leading to worse outcomes for patients.
A: Refractory anaemia (RA) lacks the additional complications seen in other classifications, resulting in a comparatively better prognosis. It typically presents with fewer blast cells and lower severity.
B: RA with ring sideroblasts shows a distinctive feature of iron accumulation in mitochondria, which is associated with a more favorable prognosis, distinguishing it from more aggressive forms of myelodysplastic syndromes.
C: RA with excess blasts presents more blast cells than RA but does not reach the severity of transformation, thus offering a better prognosis than RA with excess blasts in transformation.
A patient is suffered from vitamin K deficiency. Which of the coagulation factors will not be affected?
Rationale:
C: Factor VIII is not influenced by vitamin K deficiency, as it is not a vitamin K-dependent factor. This factor functions independently of vitamin K in the coagulation cascade, maintaining its activity despite deficiencies in vitamin K.
A: Factor II is directly impacted by vitamin K deficiency, as it requires vitamin K for its synthesis in the liver, resulting in impaired coagulation.
B: Factor VII also relies on vitamin K for synthesis, thus its levels and functionality decrease significantly in the presence of a vitamin K deficiency, leading to coagulation issues.
D: Factor IX is another vitamin K-dependent coagulation factor, which means its production and activity are compromised during vitamin K deficiency, affecting the overall coagulation process.
Patient education regarding taking iron replacements includes:
Rationale:
Iron is best taken on an empty stomach with juice. This enhances absorption, allowing the body to utilize the iron more effectively. Taking it with acidic juice, like orange juice, can further improve its uptake by the body.
A: Double the dose if they miss a dose to maintain therapeutic levels. This may lead to toxicity or severe side effects rather than maintaining safe and effective iron levels.
B: Take the iron with milk or crackers if it upsets their stomach. Dairy products can inhibit iron absorption, and taking it with crackers does not provide the necessary conditions for optimal uptake.
D: Antacids such as Tums may help an upset stomach caused by iron therapy. Antacids can interfere with iron absorption, counteracting the intended benefits of the iron supplements taken for deficiency.
Which of the following medications is given concurrently with coronary angioplasty or intervention?
Rationale:
Bivalirudin; Aspirin. Bivalirudin is an antithrombotic that effectively prevents clot formation during coronary angioplasty, while Aspirin further inhibits platelet aggregation, enhancing the overall efficacy of the procedure and reducing complications.
B: Fondaparinux; Heparin. Although both are anticoagulants, Fondaparinux is not typically used concurrently with angioplasty, and Heparin's use is less favored in this specific intervention setting.
C: Enoxaparin; Coumarins. Enoxaparin is appropriate for anticoagulation, but Coumarins are not typically administered during angioplasty due to their delayed onset and potential bleeding risks associated with percutaneous interventions.
D: Vitamin K inhibitors; Xa. Vitamin K inhibitors are unsuitable for acute procedures like angioplasty due to their long half-life, and Xa inhibitors are not standard practice for concurrent use in this context.
A nurse treating a patient taking Terbutaline should understand/do which of the following?
Rationale:
Terbutaline can cause tachycardia and angina and the patient's pulse should be monitored for an increase of greater than 20-30 beats/min.
Monitoring the pulse is essential as Terbutaline, a bronchodilator, can stimulate the heart, leading to increased heart rates. Recognizing significant changes in pulse rates ensures timely intervention, preventing potential complications related to cardiovascular responses during treatment.
B: Terbutaline can cause bradycardia and nausea and the patient should be observed for hemoptysis. Terbutaline is primarily associated with increased heart rate, not bradycardia, making this option misleading regarding its typical side effects.
C: Terbutaline can cause maculopapular rashes and dorsal acne vulgaris in adolescent men and the patient should be monitored by a dermatologist. While skin reactions can occur, this specific focus on dermatological issues is not a primary concern with Terbutaline therapy.
D: Terbutaline can cause sedation in elderly patients and they should be observed for anaphylactoid reactions. Sedation is not a common effect of Terbutaline; monitoring for anaphylaxis is unnecessary without evidence of such reactions associated with this medication.
When treating a patient who's been taking tricyclic antidepressants for the past three months and has just been prescribed albuterol, a nurse should understand that
Rationale:
C: TCAs (and MAOIs) can increase the risk of tachycardia and angina when taken with beta 2 adrenergic agonists. This interaction arises due to the sympathomimetic effects of both drug classes, potentially leading to heightened cardiovascular side effects.
A: TCAs can increase the risk of bradycardia and profound hypotension angina when taken with beta 2 adrenergic agonists. This option inaccurately focuses on bradycardia instead of the expected tachycardia.
B: TCAs can increase the risk of gastric ulcers and need to be taken with a fatty meal. This choice misrepresents the interaction, as it does not pertain to the combination with beta 2 agonists.
D: TCAs can increase the risk of pulmonary edema leading to peripheral edema and anasarca. This statement does not accurately reflect the known cardiovascular effects related to beta 2 adrenergic agonists.
All of the following statements regarding Phenylephrine are true except for
Rationale:
C: Vasoconstriction is uncommon with topical agents, but is a concern with oral agents. This statement is misleading as vasoconstriction can occur with both forms, but is more pronounced with oral administration due to systemic absorption.
A: Topical agents are usually more effective and works faster. Topical application typically results in quicker effects and higher localized concentrations, enhancing efficacy compared to systemic options.
B: Topical agents have a shorter duration. Topical formulations generally provide prolonged action compared to oral medications, as they act directly at the site of application without extensive metabolism.
D: Oral agents always lead to rebound congestion. While rebound congestion can occur with prolonged use of nasal decongestants, it is not an absolute outcome for all oral agents or in every instance.
Blood level of which clotting factor declines most rapidly after the initiation of warfarin therapy
Rationale:
Factor VII declines most rapidly after the initiation of warfarin therapy.
Factor VII has a short half-life of approximately six hours, leading to its swift reduction in circulation following warfarin administration. As vitamin K-dependent, it is significantly affected by warfarin’s mechanism of action, which inhibits its synthesis, resulting in rapid changes in blood levels compared to other factors with longer half-lives.
B: Factor IX This factor has a longer half-life, making its blood levels less susceptible to rapid decline from warfarin therapy.
C: Factor X Like Factor IX, Factor X also has a longer half-life, so its levels decrease at a slower rate than Factor VII after warfarin initiation.
D: Prothrombin With a half-life of approximately 60 hours, prothrombin levels decline much more gradually than those of Factor VII in response to warfarin therapy.
Low doses of heparin prolong
Rationale:
Low doses of heparin prolong activated partial thromboplastin time. This effect occurs because heparin enhances the activity of antithrombin, inhibiting thrombin and factor Xa, thus extending the time for blood to clot.
A: Bleeding time Low doses of heparin do not significantly affect bleeding time, which measures how long it takes for bleeding to stop, rather than the coagulation pathway involved.
C: Prothrombin time Prothrombin time evaluates the extrinsic pathway of coagulation, which heparin does not primarily influence, making this option unsuitable for describing heparin's effects.
D: Both (b) and (c) Heparin specifically prolongs activated partial thromboplastin time, while prothrombin time remains largely unaffected, invalidating this choice as a comprehensive representation of heparin's impact.
The recommended long-term antithrombotic therapy for a patient with a DVT in their leg is:
Rationale:
Direct Answer: Direct factor Xa inhibitor.
Correct Option Explanation: Direct factor Xa inhibitors are recommended for long-term management of deep vein thrombosis (DVT) due to their efficacy, predictable anticoagulation effects, and dosage convenience compared to traditional therapies. They reduce the risk of recurrence and complications associated with DVT while allowing for better patient compliance and fewer monitoring requirements than other options.
A: Low-molecular-weight heparin. This option is typically used for short-term treatment and does not provide the sustained management necessary for long-term DVT therapy.
B: Warfarin, tapered monthly. Warfarin requires regular monitoring and has numerous dietary restrictions, making it less favorable for long-term therapy compared to direct factor Xa inhibitors.
C: Aspirin, 325 mg daily. Aspirin is not effective for treating DVT on its own and lacks the anticoagulant properties necessary for long-term prevention of thromboembolic events.
A 62-year-old female patient diagnosed with early onset of dementia presents at the emergency department with her daughter who tells the attending nurse that her mother 'accidentally swallowed a lot of Methylxanthine pills'. The patient is tachycardic with fast shallow breathing. The most appropriate action is to
Rationale:
Using activated charcoal to decrease absorption is the most appropriate action. This intervention is effective in reducing the bioavailability of Methylxanthine in the gastrointestinal tract, which is crucial given the patient's symptomatic presentation of tachycardia and respiratory distress, signaling potential toxicity.
B: use a diuretic to decrease methylxanthine plasma levels. Diuretics do not effectively lower methylxanthine concentrations in the bloodstream and may exacerbate dehydration or electrolyte imbalances in this patient.
C: do nothing since increased methylxanthine plasma levels have self-limited side-effects. This approach neglects the serious symptoms currently exhibited by the patient, which indicate the potential for significant toxicity and require intervention.
D: use opioid sedatives to decrease the stimulant side-effects of methylxanthine. Opioids pose a risk of respiratory depression, which could worsen the patient's fast shallow breathing and does not address the underlying toxicity issue.
Education of patients who are taking warfarin includes discussing their diet. Instructions include:
Rationale:
Avoid foods high in vitamin K. This instruction is crucial as vitamin K can interfere with the anticoagulant effects of warfarin, making it essential for patients to maintain a consistent intake of these foods to manage their medication effectively.
A: Avoid any food containing vitamin K. Complete elimination of vitamin K is impractical and unnecessary; patients should focus on moderation and consistency rather than total avoidance for effective anticoagulation management.
C: Increase intake of iron-containing foods. While iron is important for overall health, enhancing iron intake does not directly relate to warfarin therapy or its dietary management.
D: Eat 35 grams of fiber daily. Fiber intake is generally important for health but does not specifically address the dietary considerations necessary for patients on warfarin, making it irrelevant in this context.
Low molecular weight (LMW) heparins such as Enoxaparin, are derived from standard heparin through depolymerization. In contrast to unfractioned Heparin, what is the MOA of LMW heparins?
Rationale:
LMW heparins and factor Xa inhibitors only inactivate factor Xa. This is accurate as LMW heparins primarily exert their anticoagulant effect by selectively inhibiting factor Xa, which is crucial for the coagulation cascade, thereby preventing thrombus formation and promoting safe anticoagulation therapy.
B: LMW heparins and factor IX inhibitors only activate factor X. This statement misrepresents the function of LMW heparins, which do not activate factor X but instead inhibit factor Xa to prevent clotting.
C: LMW heparins and factor XIa inhibitors only inactivate factor XIa. This option inaccurately describes the mechanism of LMW heparins, which specifically target factor Xa, not factor XIa, in their anticoagulant action.
A skilled nursing facility patient with persistent dysphagia asks the attending nurse to crush a sustained release Theophylline tablet into his applesauce. What should be the most appropriate response?
Rationale:
Crushing this medication can cause severe toxicity like respiratory arrest. Theophylline is a sustained-release medication; altering its form can lead to rapid absorption, resulting in dangerously high serum levels and respiratory complications.
A: Crushing this medication can cause profound hypoglycemia. Theophylline does not affect glucose levels significantly; hypoglycemia is unrelated to this medication’s pharmacological action and would not result from crushing it.
B: Crushing this medication can cause acute kidney damage like ESRD. Theophylline is not primarily associated with kidney damage; its main risk involves respiratory effects when altered from its intended sustained-release form.
C: Crushing this medication can ruin your snack. While unappealing, this option trivializes the serious health risks associated with crushing Theophylline, which could lead to life-threatening respiratory issues rather than mere snack disruption.
RBCs break into fragments, they are referred to as schistocytes. These type of cells are seen in
Rationale:
Schistocytes are seen in microangiopathic haemolytic anaemia. This condition involves the fragmentation of red blood cells due to mechanical damage in small blood vessels, leading to the formation of schistocytes.
A: Thalassaemia. This genetic disorder primarily affects hemoglobin production and does not typically involve the fragmentation of red blood cells into schistocytes.
C: Idiopathic thrombocytopenic purpura. This condition is characterized by low platelet counts and bleeding, but it does not result in the formation of schistocytes from RBC fragmentation.
D: Gilbert's syndrome. This benign liver condition mainly affects bilirubin metabolism and has no association with the fragmentation of red blood cells, thus not producing schistocytes.
Which of the following medications is used to prevent or treat thrombosis in clients who cannot take heparin due to heparin induced thrombocytopenia.
Rationale:
Argatroban is used to prevent or treat thrombosis in clients who cannot take heparin due to heparin induced thrombocytopenia.
Argatroban is a direct thrombin inhibitor that effectively manages anticoagulation in patients with heparin-induced thrombocytopenia, providing a safe alternative by circumventing the risks associated with heparin. This makes it a suitable choice for preventing further thrombotic events in affected individuals.
B: Fondaparinux acts as an indirect factor Xa inhibitor and is not specifically indicated for patients with heparin-induced thrombocytopenia, limiting its effectiveness in this context.
C: Dabigatran is a direct thrombin inhibitor but is not specifically approved for use in patients with heparin-induced thrombocytopenia, making it less suitable for this condition.
D: Desirudin, while a direct thrombin inhibitor, is primarily used for specific indications and lacks the established role in managing heparin-induced thrombocytopenia, reducing its appropriateness.
A patient had a deep vein thrombosis (DVT) and was on heparin and warfarin in the hospital and discharged home on warfarin. She asks her primary care nurse practitioner (NP) why she was getting both medications while in the hospital. The best response is to:
Rationale:
Warfarin is often started while a patient is still on heparin because warfarin takes a few days to reach effectiveness. This combination ensures immediate anticoagulation while allowing time for warfarin to achieve therapeutic levels.
A: Contact the hospitalist as this is not the normal guideline for prescribing these two medications and she may have had a more complicated case. This does not reflect standard practice, as combining these medications is common in managing DVT.
C: Encourage the patient to contact the customer service department at the hospital, as this was most likely a medication error during her admission. Suggesting a medication error disregards the typical protocol for transitioning from heparin to warfarin.
D: Draw anticoagulation studies to make sure she does not have dangerously high bleeding times. Monitoring bleeding times is unnecessary for understanding the rationale behind using both medications concurrently.
Aspirin 325 mg should be taken during initial acute episode of myocardial infarction. Which of the following medications can often be prescribed concurrently with aspirin and increase the risk for bleeding?
Rationale:
Clopidogrel can often be prescribed concurrently with aspirin and increase the risk for bleeding. Both medications are antiplatelet agents, which when used together, heighten the potential for hemorrhagic complications, especially during acute myocardial infarction treatment.
B: Warfarin, while an anticoagulant, is not typically used alongside aspirin in acute settings, prioritizing immediate antiplatelet therapy over anticoagulation, thus reducing its relevance to this specific question.
C: Thrombin does not represent a common concurrent medication with aspirin in myocardial infarction cases, and its reinstatement timing after surgery does not pertain to antiplatelet or bleeding risk considerations relevant here.
D: All of the above does not apply, as only clopidogrel directly relates to concurrent use with aspirin during an acute myocardial infarction and the associated bleeding risk.
A patient on oral anticoagulant therapy is commenced on sulfamethoxazole-trimethoprim, double-strength twice daily. One may expect to see the INR
Rationale:
The INR is expected to increase. Sulfamethoxazole-trimethoprim can potentiate the effects of oral anticoagulants, leading to an elevation in INR levels, thus increasing the risk of bleeding complications in patients undergoing this combination therapy.
B: If III only is correct (Remain unchanged) The INR would not remain unchanged, as sulfamethoxazole-trimethoprim significantly interacts with anticoagulants, impacting their anticoagulant effect on the INR.
C: If I and II are correct (Increase and Decrease) The INR cannot both increase and decrease simultaneously; sulfamethoxazole-trimethoprim consistently raises the INR, negating any possibility of a decrease.
D: If II and III are correct (Decrease and Remain unchanged) Both options suggest an inaccurate effect on the INR; sulfamethoxazole-trimethoprim's interaction typically leads to an increase, not a decrease or stability.
A nurse is treating a 75-year-old female patient who'd receiving heparin therapy for recurring deep vein thromboses. Before discharging the patient, the nurse should advise her to monitor for which of the following symptoms?
Rationale:
D: All of the above. The patient on heparin therapy is at risk for bleeding complications, making it crucial to monitor for symptoms such as increased heart rate, decreased blood pressure, bruising, petechiae, hematomas, and black tarry stools, all of which indicate potential hemorrhagic events requiring immediate medical attention.
A: Increased heart rate and decreased blood pressure. While these symptoms can indicate bleeding, they are not specific enough to heparin therapy complications compared to the more relevant signs listed in other options.
B: Bruising and petechiae. Although these symptoms suggest bleeding, they do not encompass the full range of potentially serious complications associated with heparin therapy, such as hematomas or gastrointestinal bleeding.
C: Hematomas and black tarry stools. These symptoms are significant indicators of bleeding; however, they do not capture the complete spectrum of warning signs that a patient should monitor while on heparin therapy.
A nurse caring for a patient diagnosed with Cystic Fibrosis should understand that the expected pharmacological action of Acetylcysteine is to
Rationale:
Acetylcysteine is designed to thin and enhance the flow of secretions in the respiratory passages. This action is crucial for patients with Cystic Fibrosis, as it helps alleviate mucus obstruction and promotes easier breathing.
B: dilate the upper respiratory passageways. Acetylcysteine does not primarily act to dilate airways; rather, it focuses on mucus reduction and clearance in the respiratory system.
C: agonize respiratory b2 adrenergic receptors. Acetylcysteine does not interact with adrenergic receptors; its primary function centers around mucolytic properties rather than stimulating bronchial dilation through adrenergic pathways.
D: antagonize a1 cholinergic receptors. This medication does not block cholinergic receptors; instead, it works as a mucolytic agent, primarily addressing mucus viscosity rather than receptor modulation.
To avoid a theophylline toxicity in her patients, a nurse should decrease the dosage of this medication when administering it concurrently with which of the following medications?
Rationale:
Concurrent administration of theophylline with cimetidine, ciprofloxacin, and other fluoroquinolone antibiotics necessitates a dosage reduction to prevent toxicity due to these drugs inhibiting theophylline metabolism, leading to elevated serum levels.
B: Phenobarbital, phenytoin, and rifampin induce the metabolism of theophylline, potentially lowering its serum concentrations, not increasing the risk of toxicity when used together.
C: Albuterol and TCAs do not significantly affect the metabolism of theophylline, thus maintaining safe serum levels without necessitating a dosage change during concurrent use.
D: None of the listed drugs pose a risk fails to recognize that certain medications, like cimetidine and ciprofloxacin, directly impact the metabolism of theophylline, increasing toxicity risk.
A patient is traveling to Southeast Asia on vacation and has come into the clinic to review their medications. They are healthy with only mild hypertension that is well controlled. They ask about getting 'a shot' to prevent blood clots like their friend did before international travel. The correct response would be to:
Rationale:
Travelers are not at high risk of blood clots if they are healthy and have well-controlled hypertension. Providing education on prevention methods, such as staying active and hydration, is appropriate.
A: Administer one dose of low-molecular-weight heparin 24 hours before travel. This approach is unnecessary for a patient without significant risk factors, potentially exposing them to undue medication side effects.
B: Prescribe one dose of warfarin to be taken the day of travel. Warfarin requires careful dosing and monitoring, making it unsuitable for a single-use scenario in a low-risk patient.
C: Consult with a hematologist regarding a treatment plan for the patient. A referral is excessive for this patient’s situation, as their mild hypertension does not warrant specialized intervention for clot prevention.
A patient taking carbamazepine needs to be started on a direct factor Xa inhibitor for antithrombotic therapy. Which of the direct factor Xa inhibitors should be avoided due to drug interactions?
Rationale:
C: Rivaroxaban should be avoided due to potential interactions with carbamazepine, which can increase the metabolism of rivaroxaban, thereby reducing its effectiveness as an antithrombotic therapy in patients.
A: Betrixaban has a lower potential for interaction with carbamazepine, making it a safer choice for patients needing antithrombotic therapy without significant drug interaction concerns.
B: Apixaban also poses a lower risk of interaction with carbamazepine, maintaining its therapeutic effectiveness without compromise in the presence of this anticonvulsant medication.
D: Edoxaban remains largely unaffected by carbamazepine, making it a viable option for antithrombotic therapy without the complications associated with drug interactions seen with rivaroxaban.
A 72 year old male with enlargement of superficial lymph nodes and mild hepatosplenomegaly is diagnosed as having chronic lymphatic leukaemia (CLL). The most important criteria for diagnosis of this disease is the
Rationale:
Absolute lymphocytosis is the most important criterion for diagnosing chronic lymphatic leukaemia (CLL). This condition is characterized by a significant increase in lymphocyte count, which is pivotal in confirming the diagnosis.
A: Presence of hypogammaglobulinaemia is a common finding in CLL but does not serve as a primary diagnostic criterion, as it can occur in various other conditions as well.
C: Male predominance highlights a statistical trend in CLL cases; however, it does not provide conclusive evidence for diagnosis and is not a definitive criterion for the disease.
D: Presence of enlarged lymph nodes is a clinical feature of CLL but lacks specificity. Enlarged lymph nodes can be associated with numerous other hematological or infectious disorders, thus not solely indicative of CLL.
The anticoagulant effects of heparin can be promptly arrested by administration of
Rationale:
Protamine sulfate. This agent directly neutralizes the anticoagulant effects of heparin by forming a stable complex, thereby reversing its anticoagulation properties rapidly and effectively, making it the preferred antidote in clinical settings.
A: Epsilon amino caproic acid. This compound primarily inhibits fibrinolysis but does not counteract the anticoagulant effects of heparin, rendering it ineffective in reversing heparin's action.
C: Adrenaline. This hormone is primarily involved in the body's fight-or-flight response and has no role in neutralizing anticoagulants like heparin, failing to address the issue at hand.
D: Vitamin K. While essential for synthesizing clotting factors, it does not counteract heparin's effects and is more relevant in managing anticoagulation related to warfarin therapy rather than heparin.
Beta 2 adrenergic agonists act by selectively activating the beta 2 receptors in the bronchial smooth muscle, resulting in bronchodilation. As a result of this
Rationale:
Beta 2 adrenergic agonists act by selectively activating the beta 2 receptors in the bronchial smooth muscle, resulting in bronchodilation. As a result of this, bronchospasm is relieved.
A: Bronchospasm is relieved. This answer accurately reflects the primary therapeutic effect of beta 2 agonists, which is to relax bronchial smooth muscle, thereby alleviating symptoms associated with bronchospasm.
B: Histamine release is potentiated. Beta 2 agonists do not enhance histamine release; instead, they primarily function to relax bronchial tissues and facilitate airflow, having no direct role in histamine activity.
C: Ciliary motility is decreased. Beta 2 agonists do not diminish ciliary function; their main action focuses on bronchodilation, maintaining or potentially enhancing the clearance of mucus by cilia.
D: All of the above. This option incorrectly suggests that all statements are valid. Only the first statement accurately describes the effect of beta 2 adrenergic agonists on bronchial smooth muscle.
A pediatric nurse is treating an 8-year-old boy who was admitted through the ER with symptoms of hallucinations, incoordination and seizures. Based on the patient's clinical presentation, the nurse correctly concludes acute toxicity with
Rationale:
Acute toxicity with antihistamines is indicated by the child's symptoms of hallucinations, incoordination, and seizures, which are consistent with the central nervous system effects often seen in overdose situations of these medications.
B: Decongestants do not typically produce hallucinations or seizures, as their primary action is on nasal congestion, lacking the central nervous system impact exhibited by the child's symptoms.
C: Mucolytics are primarily used to loosen mucus and do not cause neurological symptoms such as hallucinations or seizures, making them unlikely in this clinical scenario.
D: Acetaminophen toxicity generally leads to liver damage rather than neurological symptoms like hallucinations and seizures, which does not align with the patient's clinical presentation.
Unfractionated heparin binds to antithrombin III and inactivates clotting factor(s).
Rationale:
Unfractionated heparin binds to antithrombin III and inactivates clotting factors Xa and IIa. This dual mechanism effectively prevents clot formation, making it a crucial anticoagulant in clinical settings.
A: Xa Heparin indeed inactivates factor Xa, but this choice overlooks the additional effect on factor IIa.
B: 1 x 0 This option lacks relevance and does not correspond to any clotting factor involved in heparin's anticoagulant action.
C: IIa While heparin does inactivate factor IIa, this choice fails to acknowledge its action on factor Xa as well.
Which of the following requires IL-2 and IL-4 in the conversion of unilineage progenitor cell into mature circulating cell?
Rationale:
D: The conversion of unilineage progenitor cells into mature B lymphocytes necessitates the presence of IL-2 and IL-4, which are crucial for B cell differentiation and proliferation. These cytokines promote the maturation process essential for effective immune responses.
A: Neutrophil requires different signals for maturation and does not depend on IL-2 or IL-4 for its development from progenitor cells.
B: Eosinophil maturation primarily relies on IL-5 rather than IL-2 and IL-4, highlighting a distinct pathway for its differentiation compared to B lymphocytes.
C: Basophil development is influenced by IL-3, not IL-2 or IL-4, indicating that these cytokines are not necessary for the conversion of progenitor cells into basophils.
Myelodysplastic syndromes are a group of clonal stem cell disorders. Which of the following type has the poorest prognosis according to the FAB system of classifications?
Rationale:
D: RA with excess blasts in transformation has the poorest prognosis according to the FAB classification system, as it indicates a progression toward acute myeloid leukemia, significantly worsening survival outcomes for patients.
A: Refractory anaemia (RA) signifies a stable condition with relatively better outcomes, characterized by ineffective erythropoiesis and moderate cytopenias, thus not representing the worst prognosis.
B: RA with ring sideroblasts shows a specific form of ineffective erythropoiesis with a generally more favorable prognosis compared to other types, indicating a lower risk of progression.
C: RA with excess blasts indicates a higher number of blasts but does not reach the critical threshold of transformation, offering a better prognosis than RA with excess blasts in transformation.
A patient is suffered from vitamin K deficiency. Which of the coagulation factors will not be affected?
Rationale:
C: Factor VIII will not be affected by vitamin K deficiency. This factor is not dependent on vitamin K for its synthesis, unlike factors II, VII, and IX, which require vitamin K for proper functioning.
A: Factor II Vitamin K is essential for the synthesis of prothrombin, which is Factor II, making it directly impacted by deficiencies in this vitamin.
B: Factor VII This factor, part of the extrinsic pathway, relies on vitamin K for its synthesis, thus its levels will decrease with vitamin K deficiency.
D: Factor IX As a vitamin K-dependent coagulation factor, Factor IX will be adversely affected by vitamin K deficiency, leading to impaired coagulation.
Patient education regarding taking iron replacements includes:
Rationale:
Iron is best taken on an empty stomach with juice. This practice enhances absorption and maximizes the therapeutic effect of iron supplements, making it an optimal recommendation for patients on iron therapy.
A: Double the dose if they miss a dose to maintain therapeutic levels. Such an approach can lead to toxicity and adverse effects, undermining the safety of iron supplementation.
B: Take the iron with milk or crackers if it upsets their stomach. Dairy products and certain foods can inhibit iron absorption, which contradicts the goal of effective iron therapy.
D: Antacids such as Tums may help an upset stomach caused by iron therapy. Antacids can interfere with iron absorption, potentially diminishing the effectiveness of the iron supplements.
Which of the following medications is given concurrently with coronary angioplasty or intervention?
Rationale:
Bivalirudin; Aspirin are administered together during coronary angioplasty to enhance antithrombotic effects and reduce the risk of thrombosis, ensuring better outcomes by minimizing complications during the intervention.
B: Fondaparinux; Heparin lacks the dual antiplatelet action provided by aspirin, which is essential during coronary angioplasty for preventing clot formation and improving patient safety during the procedure.
C: Enoxaparin; Coumarins do not provide the necessary immediate antiplatelet effects needed during angioplasty, as coumarins take longer to achieve therapeutic anticoagulation, potentially increasing the risk of complications.
D: Vitamin K inhibitors; Xa are not recommended concurrently during the procedure, as they have slower onset and may lead to inadequate anticoagulation, compromising procedural efficacy and patient safety.
A nurse treating a patient taking Terbutaline should understand/do which of the following?
Rationale:
Terbutaline can cause tachycardia and angina, so the patient's pulse should be monitored for an increase of greater than 20-30 beats/min.
Monitoring pulse rate is essential as tachycardia may indicate the drug's cardiovascular effects, while angina signifies potential ischemic heart conditions. Vigilance in these areas enables timely interventions, ensuring patient safety while using terbutaline, a medication primarily used for bronchospasm relief.
B: Terbutaline can cause bradycardia and nausea, but it is primarily associated with tachycardia. Monitoring for hemoptysis is not relevant to terbutaline's common side effects.
C: Terbutaline may cause rashes, yet maculopapular rashes and dorsal acne vulgaris are not typical side effects. Dermatological monitoring is unnecessary for terbutaline-related treatment.
D: Sedation is not a common effect of terbutaline, especially in elderly patients. Anaphylactoid reactions are also not typical concerns associated with this medication's use.
When treating a patient who's been taking tricyclic antidepressants for the past three months and has just been prescribed albuterol, a nurse should understand that
Rationale:
C: TCAs (and MAOIs) can increase the risk of tachycardia and angina when taken with beta 2 adrenergic agonists. This interaction occurs due to the additive effects on cardiovascular stimulation, which can lead to increased heart rate and potential chest pain in susceptible individuals.
A: TCAs can increase the risk of bradycardia and profound hypotension angina when taken with beta 2 adrenergic agonists. This option mischaracterizes the cardiovascular effects, as TCAs primarily raise heart rate rather than lower it.
B: TCAs can increase the risk of gastric ulcers and need to be taken with a fatty meal. This choice erroneously links TCAs and gastric protection, while their interaction with albuterol is more related to cardiovascular concerns.
D: TCAs can increase the risk of pulmonary edema leading to peripheral edema and anasarca. This option inaccurately attributes fluid retention and edema directly to TCAs, not considering the specific interaction with beta 2 agonists.
All of the following statements regarding Phenylephrine are true except for
Rationale:
C: Vasoconstriction is uncommon with topical agents, but is a concern with oral agents. This statement is misleading, as topical agents can also cause significant vasoconstriction, especially with prolonged use, leading to rebound congestion.
A: Topical agents are usually more effective and works faster. Topical formulations often provide immediate relief; however, their effectiveness can vary based on the condition and individual response.
B: Topical agents have a shorter duration. While topical agents often have a quicker onset, their duration can vary and may not necessarily be shorter compared to oral formulations.
D: Oral agents always lead to rebound congestion. Not all oral agents cause rebound congestion; this phenomenon is more closely associated with the overuse of topical decongestants rather than oral medications.
Blood level of which clotting factor declines most rapidly after the initiation of warfarin therapy
Rationale:
Factor VII declines most rapidly after the initiation of warfarin therapy.
Factor VII has the shortest half-life among the vitamin K-dependent clotting factors, leading to its rapid decrease in the blood. Warfarin inhibits vitamin K epoxide reductase, affecting factors with shorter half-lives first, resulting in decreased levels of Factor VII soon after therapy begins.
B: Factor IX This factor has a longer half-life compared to Factor VII, leading to a slower decline in levels during warfarin therapy.
C: Factor X Although Factor X is affected by warfarin, its half-life is longer than that of Factor VII, resulting in a more gradual decrease in concentration.
D: Prothrombin Prothrombin has a longer half-life than Factor VII, making its reduction more gradual in response to warfarin therapy and not the fastest to decline.
Low doses of heparin prolong
Rationale:
Low doses of heparin prolong activated partial thromboplastin time.
Heparin specifically enhances the inhibitory effects of antithrombin III on several clotting factors, particularly affecting the intrinsic pathway, which is measured by activated partial thromboplastin time, thereby prolonging it effectively.
A: Bleeding time Bleeding time assesses platelet function rather than coagulation pathways, making it irrelevant to the effects of heparin.
C: Prothrombin time Prothrombin time predominantly evaluates the extrinsic pathway, which heparin does not significantly influence, leading to no prolongation.
D: Both (b) and (c) While activated partial thromboplastin time is prolonged, prothrombin time remains unchanged with low doses of heparin, making this option inaccurate.
The recommended long-term antithrombotic therapy for a patient with a DVT in their leg is:
Rationale:
Direct Answer: Direct factor Xa inhibitor is the recommended long-term antithrombotic therapy for a patient with a DVT in their leg.
Correct Option Explanation: Direct factor Xa inhibitors are preferred for long-term management of DVT due to their effectiveness in preventing recurrent thromboembolism, ease of administration, and reduced need for monitoring compared to traditional therapies. They provide reliable anticoagulation with a favorable safety profile, making them suitable for extended therapy in patients with a history of deep vein thrombosis.
A: Low-molecular-weight heparin This option is typically used for initial treatment rather than long-term management, thus lacking the sustained anticoagulation needed for preventing recurrent DVT episodes.
B: Warfarin, tapered monthly While warfarin can be effective, it requires frequent monitoring and dose adjustments, making it less convenient for long-term management compared to direct factor Xa inhibitors.
C: Aspirin, 325 mg daily Aspirin is not the recommended therapy for DVT as it is less effective in preventing thrombus formation compared to the direct factor Xa inhibitors specifically indicated for this condition.
A 62-year-old female patient diagnosed with early onset of dementia presents at the emergency department with her daughter who tells the attending nurse that her mother 'accidentally swallowed a lot of Methylxanthine pills'. The patient is tachycardic with fast shallow breathing. The most appropriate action is to
Rationale:
Using activated charcoal to decrease absorption is the most appropriate action. This intervention effectively reduces the amount of Methylxanthine entering systemic circulation, mitigating potential toxicity and alleviating the patient's symptoms of tachycardia and respiratory distress.
B: use a diuretic to decrease methylxanthine plasma levels. Diuretics do not directly address the absorption of Methylxanthine and may exacerbate dehydration or electrolyte imbalances in this patient.
C: do nothing since increased methylxanthine plasma levels have self-limited side-effects. Ignoring the situation can lead to worsening symptoms and complications, as Methylxanthine overdose can be serious and require intervention.
D: use opioid sedatives to decrease the stimulant side-effects of methylxanthine. Opioids may depress respiratory function further, which is contraindicated in a patient presenting with fast shallow breathing and tachycardia.
Education of patients who are taking warfarin includes discussing their diet. Instructions include:
Rationale:
B: Avoid foods high in vitamin K. Patients on warfarin must be cautious with vitamin K intake because it can interfere with the medication's effectiveness, leading to inconsistent anticoagulation levels and increased risk of clotting or bleeding.
A: Avoid any food containing vitamin K. Completely avoiding all vitamin K is impractical and unnecessary; instead, moderation and consistency in intake are key for effective management while on warfarin.
C: Increase intake of iron-containing foods. While iron is important for overall health, it does not directly impact warfarin’s efficacy or require dietary changes relating to vitamin K intake.
D: Eat 35 grams of fiber daily. Fiber intake is not specifically relevant to warfarin therapy; dietary focus should primarily be on managing vitamin K consumption for optimal anticoagulation control.
Low molecular weight (LMW) heparins such as Enoxaparin, are derived from standard heparin through depolymerization. In contrast to unfractioned Heparin, what is the MOA of LMW heparins?
Rationale:
LMW heparins, such as Enoxaparin, primarily function by inhibiting factor Xa, leading to anticoagulation. Their mechanism of action is more specific than unfractionated heparin, which affects multiple factors in the coagulation cascade.
B: LMW heparins and factor IX inhibitors only activate factor X. This statement inaccurately describes the role of LMW heparins, which do not activate coagulation factors but inhibit them instead.
C: LMW heparins and factor XIa inhibitors only inactivate factor XIa. This option misrepresents the action of LMW heparins, as their primary function is to specifically target and inhibit factor Xa, not factor XIa.
A skilled nursing facility patient with persistent dysphagia asks the attending nurse to crush a sustained release Theophylline tablet into his applesauce. What should be the most appropriate response?
Rationale:
Crushing this medication can cause severe toxicity like respiratory arrest. Sustained release Theophylline is designed to release the drug slowly over time; altering its form can lead to dangerous, rapid absorption and serious side effects.
A: Crushing this medication can cause profound hypoglycemia. This statement misinterprets Theophylline’s effects; it does not primarily influence blood sugar levels, making this claim irrelevant to the medication's safe administration.
B: Crushing this medication can cause acute kidney damage like ESRD. Theophylline does not directly cause kidney damage; this option misrepresents the medication's pharmacological profile and potential adverse effects.
C: Crushing this medication can ruin your snack. While it may alter the snack's enjoyment, the primary concern remains the potential for serious health risks associated with improper medication administration.